NEW YORK (GenomeWeb) – Globavir Biosciences announced today that Bio-Rad Laboratories will license its PCR-based detection technology and assay for dengue virus detection.

Globavir's PanGlob assay improves diagnostic sensitivity and efficacy across four dengue serotypes, and it displays enhanced specificity for dengue over related viruses, the firm said. Globavir has obtained rights to develop and commercialize a dengue diagnostic test platform developed at Stanford University. Its diagnostic kits have received CE-mark approval.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.